TIAM2 and ovarian carcinoma: This occurred primarily in ovarian carcinoma (n = 5), specifically in the serous histological subtype, where TIAM2 expression was increased 3.4-fold in PS-affected cases compared to remaining samples (p = 8.71e−04 uncorrected), and was also found in endometrial carcinoma (n = 1; 5.5-fold; p = 0.086 uncorrected).